12/9 RegenMD

RegenMD         Cephalon to buy 20 percent of Mesoblast in largest-ever stem cell deal December 8, 2010 at 9:36 PM   Regenerative medicine specialists, Mesoblast will see US pharmaceutical behemoth Cephalon take a 19.99 percent stake in the company as part of a licensing ... See all stories on this topic »         Viscogliosi Brothers Acts as a Strategic Advisor to Olympus Corporation on OP ... December 8, 2010 at 5:24 PM   We believe that the combination of Olympus' existing biomaterial and regenerative medicine technologies and OP-1 bone products will allow Olympus to achieve ... See all stories on this topic »         Duke Swimmer Allie Speidel Recipient of the 2011 Marshall Scholarship December 8, 2010 at 4:22 PM   A biomedical engineering major, Speidel will be continuing her education in the study of stem cell research and tissue engineering, with a research ... See all stories on this topic »         First Fully Bioprinted Blood Vessels December 8, 2010 at 4:22 PM   Data was presented at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) meeting in Orlando, Florida. ... See all stories on this topic »         First Fully Bioprinted Blood Vessels December 8, 2010 at 2:51 PM   Data was presented at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) meeting in Orlando, Florida. ... See all stories on this topic »         CIRM Board Meeting Back Online December 8, 2010 at 1:43 PM         CIRM Directors Resume Public Meeting December 8, 2010 at 1:23 PM         Trounson on Recommendations of Blue-ribbon Reviewers December 8, 2010 at 12:47 PM         CIRM Press Release on External Review Report December 8, 2010 at 12:37 PM         Stem Cell Agency Board Still in Closed Session December 8, 2010 at 12:26 PM         U of T-hosted project to develop regenerative medicine products is awarded $15 ... December 8, 2010 at 11:51 AM   The Centre for Commercialization of Regenerative Medicine was one of four projects approved by the federal government's Networks of Centre of Excellence on ... See all stories on this topic »         Astellas To Invest $10mn In US Regenerative Medicine Firm December 8, 2010 at 11:51 AM   ... stake of 10 million dollars, or about 800 million yen, in Cytori Therapeutics Inc., a California-based maker of devices used in regenerative medicine. ... See all stories on this topic »         Klein Addresses CIRM Board on His Succession Moves December 8, 2010 at 10:40 AM         Astellas signs stem cell partnership in liver disease December 8, 2010 at 10:18 AM   Regenerative medicine is an emerging field that focuses on repairing or restoring tissue function that's been lost or damaged due to the effects of injury, ... See all stories on this topic »         Cephalon strikes record $2B stem cell pact with Mesoblast December 8, 2010 at 10:18 AM   Regenerative medicine just got a big player to enter the game. Cephalon has locked itself in a tight embrace with Australia's Mesoblast, agreeing to pay ... See all stories on this topic »         Klein Defends Role in Selection of Successor December 8, 2010 at 9:49 AM         CIRM Directors Probe New Directions for Stem Cell Agency December 8, 2010 at 9:02 AM         Upcoming December 8, 2010 at 6:35 AM         Photolithography using a two-photon laser makes it possible to produce precise ... December 8, 2010 at 6:10 AM   However, the resulting materials lack the fine structure desired for advanced tissue engineering. Wan and his team developed a two-photon laser scanning ... See all stories on this topic » Nanowerk LLC         Stem-cell deal worth $2bn boosts Mesoblast December 8, 2010 at 3:25 AM   Regenerative medicine company Mesoblast Ltd has announced a deal with a US-listed biopharmaceutical company worth up to $2 billion, which could bring its ... See all stories on this topic »         The Canadian Citizenship Question – Day Four, an Answer! December 8, 2010 at 3:03 AM             This email was sent to regenmd@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here